Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Building a comprehensive genomic program for hepatocellular carcinoma.

Harring TR, Guiteau JJ, Nguyen NT, Cotton RT, Gingras MC, Wheeler DA, O'Mahony CA, Gibbs RA, Brunicardi FC, Goss JA.

World J Surg. 2011 Aug;35(8):1746-50. doi: 10.1007/s00268-010-0954-x.

2.

A primer on a hepatocellular carcinoma bioresource bank using the cancer genome atlas guidelines: practical issues and pitfalls.

Nguyen NT, Cotton RT, Harring TR, Guiteau JJ, Gingras MC, Wheeler DA, O'Mahony CA, Gibbs RA, Brunicardi FC, Goss JA.

World J Surg. 2011 Aug;35(8):1732-7. doi: 10.1007/s00268-010-0953-y.

3.

Comprehensive genome sequencing of the liver cancer genome.

Nakagawa H, Shibata T.

Cancer Lett. 2013 Nov 1;340(2):234-40. doi: 10.1016/j.canlet.2012.10.035. Epub 2012 Nov 8. Review.

PMID:
23142287
4.

Functional genomic studies: insights into the pathogenesis of liver cancer.

Han ZG.

Annu Rev Genomics Hum Genet. 2012;13:171-205. doi: 10.1146/annurev-genom-090711-163752. Epub 2012 Jun 11. Review.

PMID:
22703171
5.

Exome capture sequencing reveals new insights into hepatitis B virus-induced hepatocellular carcinoma at the early stage of tumorigenesis.

Chen Y, Wang L, Xu H, Liu X, Zhao Y.

Oncol Rep. 2013 Oct;30(4):1906-12. doi: 10.3892/or.2013.2652. Epub 2013 Aug 2.

PMID:
23912677
6.

Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.

Li S, Mao M.

Cancer Lett. 2013 Nov 1;340(2):247-53. doi: 10.1016/j.canlet.2012.09.027. Epub 2012 Oct 12. Review.

PMID:
23063663
7.

Recent advancements in comprehensive genetic analyses for human hepatocellular carcinoma.

Nishida N, Kudo M.

Oncology. 2013;84 Suppl 1:93-7. doi: 10.1159/000345897. Epub 2013 Feb 20. Review.

PMID:
23428866
8.

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.

J Pathol. 2000 Oct;192(2):207-15.

PMID:
11004697
9.

Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.

Satow R, Shitashige M, Kanai Y, Takeshita F, Ojima H, Jigami T, Honda K, Kosuge T, Ochiya T, Hirohashi S, Yamada T.

Clin Cancer Res. 2010 May 1;16(9):2518-28. doi: 10.1158/1078-0432.CCR-09-2214. Epub 2010 Apr 13.

10.

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma.

Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, Bottinger E, Friedman S, Waxman S, Llovet JM.

Hepatology. 2007 Apr;45(4):938-47.

PMID:
17393520
12.

Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus.

Zekri AR, Hassan ZK, Bahnassy AA, Sherif GM, ELdahshan D, Abouelhoda M, Ali A, Hafez MM.

Asian Pac J Cancer Prev. 2012;13(11):5433-8.

13.

Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver.

Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, Zhang X, Xiao HS, Qu J, Liu F, Huang QH, Cheng ZH, Li NG, Du JJ, Hu W, Shen KT, Lu G, Fu G, Zhong M, Xu SH, Gu WY, Huang W, Zhao XT, Hu GX, Gu JR, Chen Z, Han ZG.

Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15089-94.

14.

Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression.

Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y, Nakamura Y.

Cancer Res. 2001 Mar 1;61(5):2129-37.

15.

Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma.

Woo HG, Kim SS, Cho H, Kwon SM, Cho HJ, Ahn SJ, Park ES, Lee JS, Cho SW, Cheong JY.

PLoS One. 2014 Dec 18;9(12):e115152. doi: 10.1371/journal.pone.0115152. eCollection 2014.

16.

Medical therapies for hepatocellular carcinoma: a critical view of the evidence.

Villanueva A, Hernandez-Gea V, Llovet JM.

Nat Rev Gastroenterol Hepatol. 2013 Jan;10(1):34-42. doi: 10.1038/nrgastro.2012.199. Epub 2012 Nov 13. Review.

PMID:
23147664
17.

Transcriptional regulators in hepatocarcinogenesis--key integrators of malignant transformation.

Malz M, Pinna F, Schirmacher P, Breuhahn K.

J Hepatol. 2012 Jul;57(1):186-95. doi: 10.1016/j.jhep.2011.11.029. Epub 2012 Mar 21. Review.

18.

Molecular targets for prevention of hepatocellular carcinoma.

Blum HE.

Dig Dis. 2002;20(1):81-90. Review.

PMID:
12145424
19.

Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.

Ikeda A, Shimizu T, Matsumoto Y, Fujii Y, Eso Y, Inuzuka T, Mizuguchi A, Shimizu K, Hatano E, Uemoto S, Chiba T, Marusawa H.

Gastroenterology. 2014 Jan;146(1):222-32.e35. doi: 10.1053/j.gastro.2013.09.025. Epub 2013 Sep 19.

PMID:
24055508
20.

The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program.

Nemes B, Gelley F, Piros L, Zádori G, Görög D, Fehérvári I, Kóbori L, Sárváry E, Nagy P, Kiss A, Doros A.

Transplant Proc. 2011 May;43(4):1272-4. doi: 10.1016/j.transproceed.2011.03.077.

PMID:
21620108
Items per page

Supplemental Content

Write to the Help Desk